The so called vascular modulatory cells of the myeloid lineage (CD11b+CD45+) have been shown to be recruited to glioma via the SDF-1/CXCR4 axes upon the hypoxic up-regulation of SDF-1 and HIF-1α in tumors [81]. This evidence concerns the gene PTPRC and central nervous system cancer.